"Five Facts PhRMA Will Ignore About Rx Importation"
Five Facts PhRMA Will Ignore About Rx Importation
Emanuel, Emerson, DeLauro, Berry Call for Passage of Importation Legislation
WASHINGTON, D.C. — In advance of today’s PhRMA’s staff “briefing” on prescription drug importation, U.S. Representatives Rahm Emanuel (D-IL), Jo Ann Emerson (R-MO), Rosa DeLauro (D-CT), and Marion Berry (D-AR) released the top five facts PhRMA won’t tell you in today’s session:
#5 The same brand name drugs cost 35-55% percent less in other countries than they do in the United States. - The Congressional Budget Office
#4 Drug importation has been in place in the European Union for more than 20 years with no safety problems. – Dr. Peter Rost, Former Vice President of Marketing, Pfizer
#3 The pharmaceutical industry has imported drugs and sold them in the U.S. for decades. In fact, 40 percent of the drugs consumed by Americans today are made in foreign manufacturing plants. – Congress Daily, June 5, 2007
#2 Prescription drug importation will result in $50 billion in direct savings alone over the next decade, a $10 billion benefit to the federal budget. – The Congressional Budget Office
#1 Passage of the Pharmaceutical Market Access and Drug Safety Act will finally assure the security of our drug supply.